Anyone who wants an original brand medication today in Switzerland, even though a generic version is available, pays 40% more from their own pocket. The aim of this measure is to strengthen personal responsibility in order to curb rising healthcare costs.
And the measure is working, says Urs Kilchenmann, spokesman for the Helsana health insurance company. Since the regulation revision came into force, the proportion of generics being purchased has increased – this is shown by Helsana’s data. “This is definitely a step in the right direction.”
The current and concrete Helsana figures show that by July 2024, 25% of chronically ill people had already switched to a generic drug. In the previous year, the figure was only 12%.
More
Debate
Hosted by:
Jessica Davis Plüss
How have medicine shortages impacted your healthcare experience?
How have medicine shortages impacted you? What should be done about them?
The fact that healthcare costs can be saved if patients purchase cheaper imitation products instead of expensive original medications is undisputed among Swiss health insurance companies and their association Curafutura. The health insurance company Concordia, for example, reports that it alone could save ten million francs annually if the potential were fully exploited.
To achieve the full potential, not only do consumers need to demand more generics in pharmacies, but there also need to be more generics on the market.
One could dispense with the physical package insert and digitise it as a QR code on the packaging.
In Switzerland, the regulatory hurdles are so high that relatively few imitation products come onto the market, says Helsana spokesman Kilchenmann. However, simple measures would lower these hurdles. “For example, you could do without the physical package insert and digitise it as a QR code on the packaging,” suggests Kilchenmann.
You could also deviate from the original in terms of the packaging sizes. This would make the production of generics cheaper and therefore more attractive for the pharmaceutical companies concerned.
Translated from German by DeepL/jdp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Pope was a person full of respect: Swiss president
This content was published on
Swiss president Karin Keller-Sutter, who is attending the funeral of Pope Francis, says the pontiff was always full of respect.
Ex-sect member sentenced in Zurich for sexual abuse
This content was published on
Zurich District Court has sentenced a former member of the globally active sect "Children of God" to a partial prison sentence.
SNB chairman does not rule out slowdown in Swiss growth
This content was published on
Martin Schlegel, chairman of the Swiss National Bank (SNB), does not rule out a weakening of the Swiss economy in light of the tariff dispute.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.